Table 2.

Percentage of women exposed to hormonal contraceptives (HC) and depot medroxy progesterone acetate (DMPA) by presence and severity of disease

	Presence of disease			Severity of disease
Contraceptive used	Comparison
	Cases	Group	p value	HGSILa	LGSILb	p value
HCc	79.4	67.4	0.023	82.9	69.8	0.032
DMPAd	69.0	46.7	0.003	75.0	53.7	0.012

^a LGSIL – low risk lesions

^b HGSIL – high risk lesions

^c HC = ever use of hormonal contraceptives by use of the pill, injection or in combination with other methods.

^d DMPA = women who reported ever use of injections alone or in combination with other methods.